Login
Home
Charts
Search
Watchlist
Products

Transchem Ltd

TRANSCHEM·BSE
402.20+0.55%Tue, 22 Sept '26 13:16

Transchem Ltd

TRANSCHEM
BSE
402.20
+0.55%
|Tue, 22 Sept '26 13:16
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
492Cr
Close
Close Price
402.20
Industry
Industry
Trading
PE
Price To Earnings
73.26
PS
Price To Sales
Revenue
Revenue
0Cr
Rev Gr TTM
Revenue Growth TTM
-100.00%
PAT Gr TTM
PAT Growth TTM
47.69%

Quarterly Results

Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
000000200000
Growth YoY
Revenue Growth YoY%
490.2-100.0-100.0
Expenses
ExpensesCr
011001301111
Operating Profit
Operating ProfitCr
0-1000000-1-1-1-1
OPM
OPM%
-112.2-161.9-20.3
Other Income
Other IncomeCr
222222222245
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
122222111124
Tax
TaxCr
000100000001
PAT
PATCr
111211111123
Growth YoY
PAT Growth YoY%
130.9860.0204.995.348.521.9-41.6-40.4-52.8-61.9186.3245.4
NPM
NPM%
304.9661.930.2
EPS
EPS
0.80.91.01.41.21.10.60.80.60.41.72.8
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
000000200000
Growth YoY
Revenue Growth YoY%
490.2-100.0-100.0
Expenses
ExpensesCr
011001301111
Operating Profit
Operating ProfitCr
0-1000000-1-1-1-1
OPM
OPM%
-112.2-161.9-20.3
Other Income
Other IncomeCr
222222222245
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
122222111124
Tax
TaxCr
000100000001
PAT
PATCr
111211111123
Growth YoY
PAT Growth YoY%
130.9860.0204.995.348.521.9-41.6-40.4-52.8-61.9186.3245.4
NPM
NPM%
304.9661.930.2
EPS
EPS
0.80.91.01.41.21.10.60.80.60.41.72.8

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
000000000300
Growth
Revenue Growth%
541.6-100.0-100.0
Expenses
ExpensesCr
112112322444
Operating Profit
Operating ProfitCr
-1-1-2-1-1-2-3-2-2-1-4-4
OPM
OPM%
-423.4-55.6
Other Income
Other IncomeCr
22233277479913
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
111110000000
PBT
PBTCr
00-11125436769
Tax
TaxCr
001001111212
PAT
PATCr
00-10024314547
Growth
PAT Growth%
-60.4-567.5-443.8125.634.35,796.5-88.1-56.9239.824.3-17.847.7
NPM
NPM%
1,025.2198.7
EPS
EPS
0.0-0.2-1.00.30.319.72.31.03.44.33.55.5
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
000000000300
Growth
Revenue Growth%
541.6-100.0-100.0
Expenses
ExpensesCr
112112322444
Operating Profit
Operating ProfitCr
-1-1-2-1-1-2-3-2-2-1-4-4
OPM
OPM%
-423.4-55.6
Other Income
Other IncomeCr
22233277479913
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
111110000000
PBT
PBTCr
00-11125436769
Tax
TaxCr
001001111212
PAT
PATCr
00-10024314547
Growth
PAT Growth%
-60.4-567.5-443.8125.634.35,796.5-88.1-56.9239.824.3-17.847.7
NPM
NPM%
1,025.2198.7
EPS
EPS
0.0-0.2-1.00.30.319.72.31.03.44.33.55.5

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
1212121212121212121212
Reserves
ReservesCr
2626252625515454636771
Current Liabilities
Current LiabilitiesCr
00000000004
Non Current Liabilities
Non Current LiabilitiesCr
00000000000
Total Liabilities
Total LiabilitiesCr
3938373837636766768088
Current Assets
Current AssetsCr
2829302830555858677885
Non Current Assets
Non Current AssetsCr
1097107998922
Total Assets
Total AssetsCr
3938373837636766768088
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
1212121212121212121212
Reserves
ReservesCr
2626252625515454636771
Current Liabilities
Current LiabilitiesCr
00000000004
Non Current Liabilities
Non Current LiabilitiesCr
00000000000
Total Liabilities
Total LiabilitiesCr
3938373837636766768088
Current Assets
Current AssetsCr
2829302830555858677885
Non Current Assets
Non Current AssetsCr
1097107998922
Total Assets
Total AssetsCr
3938373837636766768088

Cash Flow

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
11-2010-1-28221-3936-3
Investing Cash Flow
Investing Cash FlowCr
0-22061231-1562
Financing Cash Flow
Financing Cash FlowCr
00000000000
Net Cash Flow
Net Cash FlowCr
1-10160-5230-3442-1
Free Cash Flow
Free Cash FlowCr
11-2011-1-2221-3937-1
CFO To PAT
CFO To PAT%
2,312.1-252.71,663.53,388.8-154.6-114.8763.998.5-935.1688.9-67.3
CFO To EBITDA
CFO To EBITDA%
-116.5-56.11,169.9-764.445.41,431.0-798.3-70.42,264.3-2,459.279.4
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
11-2010-1-28221-3936-3
Investing Cash Flow
Investing Cash FlowCr
0-22061231-1562
Financing Cash Flow
Financing Cash FlowCr
00000000000
Net Cash Flow
Net Cash FlowCr
1-10160-5230-3442-1
Free Cash Flow
Free Cash FlowCr
11-2011-1-2221-3937-1
CFO To PAT
CFO To PAT%
2,312.1-252.71,663.53,388.8-154.6-114.8763.998.5-935.1688.9-67.3
CFO To EBITDA
CFO To EBITDA%
-116.5-56.11,169.9-764.445.41,431.0-798.3-70.42,264.3-2,459.279.4

Ratios

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
21274029202027233441199492
Price To Earnings
Price To Earnings
437.595.049.20.89.418.78.27.846.373.3
Price To Sales
Price To Sales
83.815.5
Price To Book
Price To Book
0.60.71.10.80.50.30.40.30.50.52.45.9
EV To EBITDA
EV To EBITDA
-21.7-27.6-23.4-9.4-2.5-4.52.76.5-19.61.1-43.0-108.3
Profitability Ratios
Profitability Ratios
GPM
GPM%
2.40.8
OPM
OPM%
-423.4-55.6
NPM
NPM%
1,025.2198.7
ROCE
ROCE%
0.1-0.6-1.52.02.239.45.93.87.58.96.76.7
ROE
ROE%
0.1-0.6-3.20.81.138.44.31.95.66.65.15.1
ROA
ROA%
0.1-0.6-3.20.81.138.14.31.95.56.54.94.9
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
21274029202027233441199492
Price To Earnings
Price To Earnings
437.595.049.20.89.418.78.27.846.373.3
Price To Sales
Price To Sales
83.815.5
Price To Book
Price To Book
0.60.71.10.80.50.30.40.30.50.52.45.9
EV To EBITDA
EV To EBITDA
-21.7-27.6-23.4-9.4-2.5-4.52.76.5-19.61.1-43.0-108.3
Profitability Ratios
Profitability Ratios
GPM
GPM%
2.40.8
OPM
OPM%
-423.4-55.6
NPM
NPM%
1,025.2198.7
ROCE
ROCE%
0.1-0.6-1.52.02.239.45.93.87.58.96.76.7
ROE
ROE%
0.1-0.6-3.20.81.138.44.31.95.66.65.15.1
ROA
ROA%
0.1-0.6-3.20.81.138.14.31.95.56.54.94.9
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Transchem Limited is a company in the middle of a deliberate reinvention. After decades as a mushroom exporter, it sold its sole factory in 2020 and spent years as a shell with a treasury portfolio, before re-emerging first as a modest trader of agricultural goods and then, in a decisive break, as a financial-services platform backed by a NYSE-listed strategic investor. The recurring logic is one of patient capital redeployment: monetise a legacy asset, preserve the cash, and redirect it into an entirely new industry with higher growth potential. # Business segments A single operating business today - agricultural commodity trading - with a financial-services engine under construction that will redefine the company once completed. ## 1. Agricultural trading: the placeholder that keeps the lights on **The company buys and sells soya and bagasse in the domestic market, generating just enough activity to maintain its listed status while the financial-services pivot takes shape.** - **A restart, not a legacy** - the company re-entered agricultural markets only after selling its mushroom plant, recognising a need to diversify and generate operational revenue for the first time in years. - **Simple buy-sell model** - it purchases goods like soya and bagasse and resells them, with higher volumes in FY25 driving the revenue line compared to the prior year. - **Tied to a promoter-linked supplier** - a meaningful portion of the business involves reselling mushroom and other agricultural goods sourced from Manegrow Agro Products, an entity where a promoter holds significant influence, on market-based commercial terms. - **No structural advantage** - the company operates only in India, has a single operating segment with no reportable geographic or business divisions, and employs just ten people, underscoring the business's interim nature. ## 2. Financial services: the intended future, bought with a warrant cheque **The company is acquiring a stock-broking firm and has raised capital from a NYSE-listed backer to build a full-spectrum financial-services platform spanning broking, advisory, and fund management.** - **Acquisition of a ready-made broker** - it has signed a non-binding term sheet to acquire 100% of Greshma Shares & Stocks Limited, a Mumbai-based firm that is a member of NSE and BSE and a CDSL depository participant, offering equity and derivatives trading, IPO distribution, and wealth management. - **Funded by a strategic giant** - a preferential warrant issue of Rs. 461.25 Crores was led by Bakkt Opco Holdings, a subsidiary of NYSE-listed Bakkt, Inc., which took 64.42% of the diluted capital, with the proceeds earmarked for acquisitions in broking and allied financial services. - **Licence to build a full platform** - shareholders approved a new objects clause permitting the company to act as a stock and commodity broker, depository participant, investment advisor, portfolio manager, underwriter, and sponsor for mutual funds and investment trusts, with explicit scope to use AI and machine learning in service delivery. - **Capital allocated for lending** - the company plans to deploy part of the raised funds into margin trading facilities, aiming to build a loan book secured against shares while maintaining the regulatory net-worth and liquidity buffers required by SEBI and the exchanges. # Group structure and partners **A promoter group that has steadily diluted control to make way for a single strategic investor that now holds the economic majority.** - **Promoters in retreat** - as of early 2022, promoters Vijay K Choraria and Priyanka Finance held a combined 44.76%, but the June 2026 warrant issue to non-promoters has reshaped the register entirely. - **Bakkt is the new anchor** - Bakkt Opco Holdings, LLC, a subsidiary of Bakkt, Inc. (NYSE: BKKT), holds warrants representing 64.42% of the fully diluted share capital, making it the dominant economic stakeholder once warrants are exercised. - **No current subsidiaries** - the company has no subsidiaries, associates, or joint ventures today; the Greshma acquisition will create its first wholly owned subsidiary upon completion. - **Lean governance** - the board is chaired by an independent director and includes a whole-time director, with a company secretary and CFO rounding out the key managerial personnel, supported by recently rotated statutory and internal auditors.

Documents — Transchem Ltd

  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/xytxirx8qhulasdkt99fgyon.pdf
  • Q1 FY2025 Quarterly Result (Jun 2024, PDF): https://www.stockscans.in/document/2nv4k30alw9m48ksanzzutha.pdf
  • Q4 FY2024 Quarterly Result (Mar 2024, PDF): https://www.stockscans.in/document/c58m371kd486ogid86qs7hx2.pdf
  • Q3 FY2024 Quarterly Result (Dec 2023, PDF): https://www.stockscans.in/document/es1q86mqctv1alvuduk4k2id.pdf
  • Q2 FY2024 Quarterly Result (Sep 2023, PDF): https://www.stockscans.in/document/o0ku3hu3ug9bert6q4epzgm1.pdf
  • Q1 FY2024 Quarterly Result (Jun 2023, PDF): https://www.stockscans.in/document/z1gn69ddsxuwvg3y329g9d71.pdf
  • Q3 FY2023 Quarterly Result (Dec 2022, PDF): https://www.stockscans.in/document/e7wte2wf2ufd5391r56cflrd.pdf
  • Q2 FY2023 Quarterly Result (Sep 2022, PDF): https://www.stockscans.in/document/uionzhdmfbveu6l4x689u3ua.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/6r2t06cii880awl561k12erk.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/k1y1dvap3m6pg55yllwf7zmb.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/5xje3jlfhl05l6ltfsrvjljv.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/tx4b0uechfvmxf66i456nhxg.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/gujdxsllc5z6151as0w2icx0.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/s0yq22ob03732n3xvpjkghsv.pdf